Coronavirus Aid, Relief, and Economic Security (CARES) Act (H.R. 748)

Congress has been working on Phase III of coronavirus relief and a vote on the package is expected to occur the week of Mar 23-27, 2020. Provisions in the legislation include human resources, hospital payment, patient cost-sharing, coverage of diagnostics and vaccines, and supply shortages. For many of the provisions, HHS is directed to implement through regulations released in the next six months. Thus, interim final rules may be used and the traditional notice and comment period would not apply.

In addition, a package of budget extenders related to HHS are included, including a delay of scheduled reductions in disproportionate share hospital (DSH) payments through 11/30/2020. Other extenders include the Medicaid Money Follows the Person demonstration and the Teaching Health Center Grade Medical Education Program, which will be funded through 11/30/2020.

This summary is organized first by cross-cutting themes and then by order in the legislation.

Cross-Cutting Themes

Payment to Hospitals and Other Providers

Temporarily suspends the Medicare sequester from May 1 through December 31, 2020. The sequester will be extended by one year beyond current law to compensate for the suspension.
An add-on payment of 20% under the inpatient prospective payment system (IPPS) will be applied for discharges occurring during the emergency period of individuals diagnosed with COVID-19.
Waives the 3-hour rule for inpatient rehabilitation facilities (IRFs) during the emergency declaration.
For long-term care hospitals (LTCHs), the site-neutral payment rate provisions and the 50 percent rule are waived during the emergency declaration.
The bill prevents scheduled reductions in Medicare payments for DME during the emergency.
Part D plans will be required to provide a 90-day supply of prescription medications if requested by a beneficiary during the COVID-19 emergency period.
Prevents scheduled reductions in Medicare payments for clinical diagnostic laboratory furnished to beneficiaries in 2021 and delays by one year the upcoming reporting period during which laboratories are required to report private payer data.
Expands the existing Medicare accelerated payment program for the duration of COVID-19. Qualified facilities can request up to a six-month advanced lump sum or periodic payment.

Coverage of Testing and Vaccines

Testing for COVID-19 is to be covered by private insurance plans without cost sharing.
For testing covered with no cost to patients, an insurer is required to pay either the rate specified in its contract with the provider or a cash price posted by the provider.
- Providers of COVID-10 diagnostic tests will have to post publicly online a cash price.
Insurance plans will have to cover any qualifying coronavirus preventive services, particularly a vaccine, with no cost sharing.
- This means coverage of a vaccine or other item or service that has in effect an “A” or “B” rating in the current recommendations of the USPSTF or the ACIP.
Eliminates cost-sharing for a future COVID-19 vaccine in Medicare Part B.
Clarifies previous COVID-19 bill to ensure that Part B beneficiaries can receive all tests for COVID-19 in Part B with no cost-sharing.

Provider-Focused Provisions

Provides liability protections for volunteer health care professionals who provide services during the COVID-19 public health emergency.
- Section 3216 allows HHS secretary to reassign members of the National Health Services Corps to sites close to the ones originally assigned to, with member’s agreement, to respond to PHE.
Aligns 42 CFR Part 2 regulations with HIPAA, allowing disclosure to covered entities of records related to substance use disorder (SUD) with initial patient consent.
HHS will have to issue guidance on what information in a patient’s record can be shared during the public health emergency no later than 6 months after this bill is enacted.
An additional $1.32 billion in funding to community health centers will be appropriated.
Reauthorizes grant programs from the Health Resources and Services Administration (HRSA) related to telehealth and quality improvement in rural community health.
Appropriates money for FYs 2021 through 2025 for health care workforce programs under 42 U.S.C. 293, which outline support for programs of excellence in health profession education for under-represented minority individuals. The bill also directs the HHS secretary to develop comprehensive and coordinated plan for health workforce programs.
For testing covered with no cost to patients, an insurer is required to pay either the rate specified in its contract with the provider or a cash price posted by the provider.
- Providers of COVID-10 diagnostic tests will have to post publicly online a cash price.

Telehealth and Face-to-Face Requirements

Eliminates requirement from previous coronavirus bill that limited Medicare telehealth expansion to situations where the physician or other professional has treated the patient in the past three years.
Allows FQHCs and Rural Health Clinics (RHCs) to serve as a distant site for telehealth consultations, meaning practitioners can be located at these facilities during the time of a telehealth service. The bill also allows these facilities to furnish telehealth to beneficiaries in their home.
- Medicare will reimburse for these services based on payment rates similar to the national average payment rates for comparable telehealth services under the PFS. Costs associated with these services will be excluded from both the FQHC PPS and RHC all-inclusive rate calculation.
During the COVID-19 emergency period, the requirement that a nephrologist conduct some of the required periodic evaluations for home-dialysis patients face-to-face will be allowed via telehealth.
During the COVID-19 emergency period, hospice physicians and nurse practitioners may use telehealth technologies to fulfill face-to-face recertification requirements.
Directs HHS to consider ways to encourage use of telecommunications systems, including for remote patient monitoring, to furnish home health services consistent with a beneficiary care plan during the COVID-19 emergency period.
Physician assistants, nurse practitioners, and clinical nurse specialists may order HH services.
High deductible health plans (HDHPs) may cover telehealth services prior to a patient reaching the deductible and still qualify as an HDHP

Addressing Supply Shortages

The bill clarifies that the Strategic National Stockpile can include medical supplies, such as the swabs necessary for COVID-19 diagnostic testing.
Establishes respiratory protective devices, including masks and respirators, as covered countermeasures, providing permanent liability protection for manufacturers of these items when determined to be a priority for use during an emergency declaration
Requires that the FDA prioritize and expedite the review of drug applications and inspections to prevent or mitigate a drug shortage
Drug manufacturers will have to report additional information when there is an interruption in supply caused by active pharmaceutical ingredients (APIs), including information about drug volume. Manufacturers will have to develop risk management plans for relevant drugs and APIs.
During a public health emergency, a medical device manufacturer will be required to submit information about a device or device component shortage upon request.
- If based on this information, HHS concludes that there is or will likely be a shortage, submission reviews will be prioritized and expedited by the FDA as well as inspections.
- HHS will also maintain a list of devices determined to be in shortage.

Medicaid-Related Provisions

The bill ensures that states are able to receive the Medicaid 6.2 percent FMAP increase.
- CMS already released FAQs and other documents for states related to the FMAP increase.
Clarifies a section of previous COVID-19 bill to ensure that uninsured individuals can receive a COVID-19 test and related services with no cost-sharing in any state Medicaid program that elects to offer such an enrollment option.
Allows state Medicaid programs to pay for direct support professionals.

Order in the Legislation

Title I— Keeping American Workers Paid and Employed Act

Increases the government guarantee of loans made for the Payment Protection Program under section 7(a) of the Small Business Act to 100 percent through December 31, 2020.
Authorizes SBA to provide additional financial awards to resource partners (Small Business Development Centers and Women’s Business Centers) to provide counseling, training, and education on SBA resources and business resiliency to small business owners affected by COVID-19.
Allows for federal grant funds appropriated to support the State Trade Expansion Program (STEP) in FY 2018 and FY 2019 to remain available for use through FY 2021.
Eliminates the non-federal match requirement for WBCs for a period of three months.
Establishes that the borrower shall be eligible for loan forgiveness equal to the amount spent by the borrower during an 8-week period after the origination date of the loan on payroll costs, interest payment on any mortgage incurred prior to 2/15/2020, payment of rent on any lease in force prior to 2/15/2020, and payment on any utility for which service began before 2/15/2020.
Section 1107 provides direct appropriations to undertake provisions in this Title.
Authorizes $10M for Minority Business Development Agency within the Department of Commerce.
Establishes the authority of the U.S. Department of Treasury, the Farm Credit Administration, and other federal financial regulatory agencies to authorize bank and nonbank lenders to participate, including insured credit unions in loans made under the Paycheck Protection Program.
Expands eligibility for access to Economic Injury Disaster Loans (EIDL) to include Tribal businesses, cooperatives, and ESOPs with fewer than 500 employees or any individual operating as a sole proprietor or an independent contractor during the covered period (1/31/2020 to 12/31/2020).
Directs $25M for the SBA to offer resources and services in 10 most commonly spoken languages.
Defines a covered loan as an existing 7(a) (including Community Advantage), 504, or microloan product. Paycheck Protection Program (PPP) loans are not covered.
Amends the Small Business Reorganization Act to increase the eligibility threshold to file under subchapter V of chapter 11 of the U.S. Bankruptcy Code to businesses with less than $7.5M of debt. The increase sunsets after one year and the eligibility threshold returns to $2,725,625.

Title II—Assistance for American Workers, Families, and Businesses

Subtitle A – Unemployment Insurance Provisions (Relief for Workers Affected by Coronavirus Act)

Creates a temporary Pandemic Unemployment Assistance program through 12/31/2020 to provide payment to those not traditionally eligible for unemployment benefits (self-employed, independent contractors, those with limited work history, and others) who are unable to work as a direct result of the coronavirus public health emergency.
Additional $600 per week payment to each recipient of unemployment insurance or Pandemic Unemployment Assistance for up to four months.
Provides funding to pay the cost of the first week of unemployment benefits through 12/31/2020 for states that choose to pay recipients as soon as they become unemployed instead of waiting one week before the individual is eligible to receive benefits.
Provides an additional 13 weeks of unemployment benefits through 12/31/2020 to help those who remain unemployed after state unemployment benefits are no longer available.
Provides funding to support “short-time compensation” programs, where employers reduce employee hours instead of laying off workers and employees with reduced hours receive a pro-rated unemployment benefit. This provision would pay 100 percent of the costs through 12/31/2020.
Other provisions related to the Railroad Unemployment Insurance Act.

Subtitle B – Rebates and Other Individual Provisions

All U.S. residents with AGI up to $75,000 ($150,000 married), who are not a dependent of another taxpayer and have a work eligible SSN, are eligible for the full $1,200 ($2,400 married) rebate. In addition, they are eligible for an additional $500 per child.
Waives the 10-percent early withdrawal penalty for distributions up to $100,000 from qualified retirement accounts for coronavirus-related purposes made on or after 1/1/2020.
Waives the required minimum distribution rules for certain defined contribution plans and IRAs for calendar year 2020.
Encourages contributions to churches and charitable organizations in 2020 by permitting deduction of up to $300 of cash contributions, whether deductions are itemized or not.
Increases the limitations on deductions for charitable contributions by individuals who itemize, as well as corporations. For individuals, the 50-percent of adjusted gross income limitation is suspended for 2020. For corporations, the 10-percent limitation is increased to 25 percent of taxable income.

Subtitle C – Business Provisions

Provides a refundable payroll tax credit for 50 percent of wages paid to employees during the COVID-19 crisis. The credit is available to employers whose (1) operations were fully or partially suspended, or (2) gross receipts declined by more than 50 percent.
Allows employers to defer payment of the employer share of the Social Security tax they otherwise are responsible for paying to the federal government with respect to their employees. The provision requires that the deferred employment tax be paid over the following two years, with half paid by 12/31/2021 and the other half by 12/31/2022.
Relaxes the loss limitations on a company or pass-through.
Accelerates the ability of companies to recover AMT credits, permitting companies to claim a refund now and obtain additional cash flow during the COVID-19 emergency.
Temporarily increases the interest expense businesses are allowed to deduct by increasing 30-percent limitation to 50 percent of taxable income (with adjustments) for 2019 & 2020.

Title III—Supporting America’s Health Care System in the Fight Against COVID-19

Subtitle A – Health Provisions

Part I – Addressing Supply Shortages

The bill clarifies that the Strategic National Stockpile can include medical supplies, such as the swabs necessary for COVID-19 diagnostic testing.
Establishes respiratory protective devices, including masks and respirators, as covered countermeasures, providing permanent liability protection for manufacturers of these items when determined to be a priority for use during an emergency declaration
Requires that the FDA prioritize and expedite the review of drug applications and inspections to prevent or mitigate a drug shortage
Drug manufacturers will have to report additional information when there is an interruption in supply caused by active pharmaceutical ingredients (APIs), including information about drug volume. Manufacturers will have to develop risk management plans for relevant drugs and APIs.
During a public health emergency, a medical device manufacturer will be required to submit information about a device or device component shortage upon request.
- If based on this information, HHS concludes that there is or will likely be a shortage, submission reviews will be prioritized and expedited by the FDA as well as inspections.
- HHS will also maintain a list of devices determined to be in shortage.

Part II – Access to Health Care for COVID-19 Patients

Clarifies that all testing for COVID-19 is to be covered by private insurance plans without cost sharing, including those tests without an EUA by the FDA.
For COVID-19 testing, requires an insurer to pay either the rate specified in a contract between the provider and the insurer, or a cash price posted by the provider.
Provides free coverage without cost-sharing of a vaccine within 15 days for COVID-19 that has in effect a rating of “A” or “B” in the current recommendations of the USPTF or a recommendation from the Advisory Committee on Immunization Practices (ACIP).
Provides $1.32 billion in supplemental funding to community health centers on the front lines of testing and treating patients for COVID-19.
Reauthorizes HRSA grant programs that promote the use of telehealth technologies for health care delivery, education, and health information services.
Reauthorizes HRSA grant programs to strengthen rural community health by focusing on quality improvement, increasing health care access, coordination of care, and integration of services. Rural residents are disproportionately older and more likely to have a chronic disease, which could increase their risk for more severe illness if they contract COVID- 19.
Establishes a Ready Reserve Corps to ensure we have enough trained doctors and nurses to respond to COVID-19 and other public health emergencies.
Makes clear that doctors who provide volunteer medical services during the public health emergency related to COVID-19 have liability protections.
Allows the Secretary of HHS to reassign members of the National Health Service Corps to sites close to the one to which they were originally assigned, with the member’s agreement, in order to respond to the COVID-19 public health emergency.
Allows for additional care coordination by aligning the 42 CFR Part 2 regulations, which govern the confidentiality and sharing of substance use disorder treatment records, with Health Insurance Portability and Accountability Act (HIPAA), with initial patient consent.
Waives nutrition requirements for Older Americans Act (OAA) meal programs during the public health emergency to ensure seniors can get meals if certain options are not available.
Requires the Department of HHS to issue guidance on what is allowed to be shared of patient record during the public health emergency related to COVID-19.
Reauthorizes Healthy Start, a program that provides grants to improve access to services for women and families and may need additional support during the public health emergency.
Directs HHS to carry out an initiative to improve awareness of the importance and safety of blood donation and the continued need for donations during the public health emergency.

Part III – Innovation

Allows the Biomedical Advanced Research and Development Authority (BARDA) to more easily partner with private sector on research and development
Provides Breakthrough Therapy designations for animal drugs that can prevent human diseases – i.e. speed up the development of drugs to treat animals to help prevent animal- to-human transmission.

Part IV – Health Care Workforce

Reauthorizes and updates Title VII of the PHSA, which pertains to programs to support clinician training and faculty development, including the training of practitioners in family medicine, general internal medicine, geriatrics, pediatrics, and other medical specialties.
Directs HHS to develop a comprehensive and coordinated plan for health workforce programs, which may include performance measures and the identification of gaps between the outcomes of such programs and relevant workforce projection needs.
Reauthorizes and updates Title VIII of the PHSA, which pertains to nurse workforce training programs. Updates reporting requirements to include information on the extent to which Title VIII programs meet the goals and performance measures for such activities, and the extent to which HHS coordinates with other Federal departments on related programs.
Permits Nurse Corps loan repayment beneficiaries to serve at private institutions under certain circumstances.

Subtitle B – Education Provisions

Various provisions related to waivers, grants, and loans for education and institutions.

Subtitle C – Labor Provisions

Creates a limitation stating an employer shall not be required to pay more than $200 per day and $10,000 in the aggregate for each employee under this section.
Creates a limitation stating an employer shall not be required to pay more than $511 per day and $5,110 in the aggregate for sick leave or more than $200 per day and $2,000 in the aggregate to care for a quarantined individual or child for each employee under this section.
Provides that applications for unemployment compensation and assistance with the application process be accessible in two ways: in person, by phone, or online.
Allows the Director of the OMB to exclude for good cause certain Executive Branch employees from the Paid Family Leave mandate. Allows the Director of the OMB to exclude for good cause certain Executive Branch employees from the Paid Sick Leave mandate.
Allows an employee who was laid off by an employer March 1, 2020, or later to have access to paid family and medical leave in certain instances if they are rehired by the employer. Employee would have had to work for the employer at least 30 days prior to being laid off.
Allows employers to receive an advance tax credit from Treasury instead of having to be reimbursed on the back end.
Amends Section 518 of ERISA to provide the DoL the ability to postpone certain ERISA filing deadlines for a period of up to one year in the case of a public health emergency.
Provides single employer pension plan companies with more time to meet their funding obligations by delaying the due date for any contribution otherwise due during 2020 until January 1, 2021. At that time, contributions due earlier would be due with interest.
Amends a the definition of CSEC Plans to provide that a pension plan will be a CSEC plan if, as of January 1, 2000, the plan was sponsored by an employer that (i) is exempt from taxation under Code section 501(c)(3), (ii) has been in existence since 1938, (iii) conducts medical research directly or indirectly through grant making, and (iv) has as its primary exempt purpose providing services with respect to mothers and children. This section is effective for plan years beginning after 12/31/2018.
Ensures that federal contractors who cannot perform work at their duty-station or telework because of the nature of their jobs due to COVID-19, continue to get paid.

Subtitle D – Finance Committee

Allows a high-deductible health plan (HDHP) with a health savings account (HSA) to cover telehealth services prior to a patient reaching the deductible, increasing access for patients who may have the COVID-19 virus and protecting other patients from potential exposure.
Allows patients to use funds in HSAs and FSAs for the purchase of OTC medical products, including those needed in quarantine and social distancing, without physician prescription.
Eliminates the requirement in Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020 (Public Law 116-123) that limits the Medicare telehealth expansion authority during the emergency period to situations where the physician or other professional has treated the patient in the past three years. This would enable beneficiaries to access telehealth, including in their home, from a broader range of providers.
Allows FQHCs and RHCs to serve as a distant site for telehealth during emergency period.
Eliminates a requirement during the COVID-19 emergency period that a nephrologist conduct some of the required periodic evaluations of a patient on home dialysis face-to-face, allowing these vulnerable beneficiaries to get more care in the safety of their home.
Allows, during the COVID-19 emergency period, qualified providers to use telehealth technologies in order to fulfill the hospice face-to-face recertification requirement.
Requires HHS to issue clarifying guidance encouraging the use of telecommunications systems, including remote patient monitoring, to furnish home health services consistent with the beneficiary care plan during the COVID-19 emergency period.
Allows PAs, NPs, and other professionals to order home health services for beneficiaries, reducing delays and increasing beneficiary access to care in the safety of their home.
Temporarily lifts the Medicare sequester, which reduces payments to providers by 2 percent, from 5/1/2020 through 12/31/2020. The sequester would be extended by one-year beyond current law to provide relief without worsening Medicare’s financial outlook.
Increases the payment that would otherwise be made to a hospital for treating a patient admitted with COVID-19 by 20 percent. This add-on payment would be available through the duration of the COVID-19 emergency period.
Provides acute care hospitals flexibility, during the emergency period, to transfer patients out of their facilities and into alternative care settings in order to prioritize resources.
Prevents scheduled reductions in Medicare payments for durable medical equipment.
Enables beneficiaries to receive a COVID-19 vaccine in Medicare Part B with no cost-sharing.
Require that Medicare Part D plans provide up to a 90-day supply of a prescription medication if requested by a beneficiary during the COVID-19 emergency period.
Allows state Medicaid programs to pay for direct support professionals, caregivers trained to help with ADLs, to assist disabled individuals in the hospital to help free up beds.
Clarifies sections of FFCRA (P.L. 116-127) by ensuring uninsured individuals can receive a COVID-19 test and related service with no cost-sharing in any state Medicaid program that elects to offer such enrollment option and by ensuring that beneficiaries can receive all tests for COVID-19 in Medicare Part B with no cost-sharing.
Prevents scheduled reductions in Medicare payments for clinical diagnostic laboratory tests furnished to beneficiaries in 2021. It would also delay by one year the upcoming reporting period during which laboratories are required to report private payer data.
Expands, for the duration of the COVID-19 emergency period, the existing Medicare accelerated payment program for hospitals. Specifically, qualified facilities would be able to request up to a six-month advanced lump sum or periodic payment. This advanced payment would be based on net reimbursement represented by unbilled discharges or unpaid bills. Most hospital types could elect to receive up to 100 percent of the prior period payments, with Critical Access Hospitals able to receive up to 125 percent. Finally, a qualifying hospital would not be required to start paying down the loan for four months and would also have at least 12 months to complete repayment without a requirement to pay interest.
This section would amend a section of the FFCRA of 2020 (Public Law 116-127) to ensure that states are able to receive the Medicaid 6.2 percent FMAP increase.

Subtitle E – Health and Human Services Extenders

Part I – Medicare Provisions

Increases payments for the work component of physician fees in areas where labor cost is determined to be lower than the national average through December 1, 2020.
Provides funding for HHS to contract with a consensus-based entity to carry out duties related to quality measurement & performance improvement through 11/30/2020.
Extends funding for beneficiary outreach/counseling related to low-income programs through 11/30/2020.

Part II – Medicaid Provisions

Extends the Medicaid Money Follows the Person demonstration that helps patients transition from the nursing home to the home setting through 11/30/2020.
Extends the Medicaid spousal impoverishment protections program through 11/30/2020 to help a spouse of an individual who qualifies for nursing home care to live at home.
Delays scheduled reductions in Medicaid DSH payments through 11/30/2020.
Extends the Medicaid Community Mental Health Services demonstration for those with mental health and substance use disorders through 11/30/2020.

Part III – Human Services and Other Health Programs

Extends the Health Professions Opportunity Grants (HPOG) program through 11/30/2020 at current funding levels. This program provides funding to help low-income individuals obtain education and training in high-demand, well-paid, health care jobs.
Extends TANF and related programs through November 30, 2020.

Part IV – Public Health Provisions

Extends mandatory funding for CHCs, the NHSC, and the Teaching Health Center Graduate Medical Education Program at current levels through 11/30/2020.
Extends mandatory funding for the Special Diabetes Program for Type I Diabetes and the Special Diabetes Program for Indians at current levels through 11/30/2020.

Subtitle F – Over-the-Counter Drugs

Reforms the regulatory process for OTC drug monographs by allowing the FDA to approve changes administratively, rather than going through a full notice and comment rulemaking.
Clarifies that an OTC drug not in compliance with monograph requirements is misbranded.
Clarifies that nothing in this bill will apply to drugs previously excluded by the FDA from the Over-the-Counter Drug Review under a specified Federal Register document.
Clarifies that sponsors of sunscreen ingredients with pending orders have option to see review in accordance with the Sunscreen Innovation Act or new monograph review process.
Requires an annual update to Congress regarding FDA’s progress in evaluating certain pediatric indications for certain cough and cold monograph drugs for children under age six.
Includes technical corrections to the FDA Reauthorization Act of 2017 and existing law.
Fees paid pursuant to this section are dedicated to FDA review of OTC monograph drugs.
Establishes a new FDA user fee to allow the agency to hire additional staff members to ensure there is adequate agency oversight to approve changes to OTC drugs.

Title IV—Economic Stabilization & Assistance to Severely Distressed Sectors of Economy

Subtitle A—Coronavirus Economic Stabilization Act of 2020

This subtitle is related to the emergency relief and taxpayer protections for eligible businesses, which are defined as a United States business that has not otherwise received adequate economic relief in the form of loans or loan guarantees provided under this Act.
Provides $500 billion to Treasury’s Exchange Stabilization Fund to provide loans, loan guarantees, and other investments as specified in this subtitle.
Authorizes the FDIC to temporarily establish a debt guarantee program to guarantee debt of solvent insured depositories and depository institution holding companies.
Offers waivers/flexibility for nonbank financial companies and community banks.
Waives for a two-year period the requirement for a separate act of Congress to authorize certain projects exceeding $50 million and that any amounts unused in the Defense Production Act Fund at the end of the FY that exceed $750 million be swept.
Any company in which the President, Vice President, an executive department head, Member of Congress, or any of such individual’s spouse, child, son-in-law, or daughter- in-law own over 20 percent of the outstanding voting stock shall not be eligible for loans, loan guarantees, or other investments provided under this Title.
Establishes a Congressional Oversight Commission with oversight of this Title.
Requires that furnishers to credit reporting agencies who agree to account forbearance, or agree to modified payments, report such obligation or account as “current” or as the status reported prior to the accommodation unless the consumer becomes current.
Prohibits foreclosures on all federally-backed mortgage loans for a 60-day period beginning 3/18/2020. Provides up to 180 days of forbearance for borrowers of a federally-backed mortgage loan who have experienced a financial hardship related to COVID-19 emergency.
Provides up to 90 days of forbearance for multifamily borrowers with a federally backed multifamily mortgage loan who have experienced a financial hardship.
For 120 days beginning on the date of enactment, landlords are prohibited from initiating legal action to recover possession of a rental unit or to charge fees, penalties, or other charges to the tenant related to such nonpayment of rent where the landlord’s mortgage on that property is federally-backed.
All authority to make new loans, loan guarantees, or other investments provided under this Title shall terminate on 12/31/2020 and duration of all loans shall not exceed five years.

Subtitle B—Air Carrier Worker Support

As specified in this subtitle, provides financial assistance for the exclusive use of employee wages, salaries, and benefits in the amounts of up to $25B for passenger air carriers, up to $4B for cargo air carriers, and up to $3B for airline contractors. Provides for $100M for administrative fees associated with providing the financial assistance.

Title V— Coronavirus Relief Funds

Provides $150B to States, Territories, & Tribal governments for expenditures incurred due to the COVID-19 public health emergency in the face of revenue declines, allocated by population proportions, with a minimum of $1.25B for states with small populations.

Applied Policy ®